A randomized, double‐blind, placebo‐controlled trial of lenalidomide in the treatment of moderately severe active Crohn’s disease
暂无分享,去创建一个
A. Forbes | J. Mansfield | J. Zeldis | D. Manning | A. Hawthorne | C. J. Hawkey | C. Probert | M. Parkes | A. Cooper | C. Hawkey | R. Perowne | R. Perowne